一种可用于生物呼吸代谢过程中实时动态联合检测O_2和CO_2的传感技术

发展并建立了用于快速联合检测Ｏ２和ＣＯ２气体的调制电位脉冲微库仑法．对在非水电化学体系中实现两者一次检测的实时动态传感技术进行了系统研究．结果表明，这一新的电化学传感技术可望用来实时监测生物呼吸代谢过程中Ｏ２和ＣＯ２气体分压的动态变化     

Inducing dopaminergic differentiation of expanded rat mesencephalic neural stem cells by ascorbic acid in vitro

Ascorbic acid (AA) induced differentiation of neural stem cells (NSCs) into dopaminergic (DAergic) neurons is reported.NSCs derived from rat mesencephalon were maintained and expanded in a defined medium containing mitogens of basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF).Compared with the control, ascorbic acid treatment led to more DAergic neuronal differentiation as indicated by the expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT), which are specific markers of dopamine neurons.AA induction also enhanced expression of Nurr1 and Shh.PD98059, an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway, could block AA-induced Nurr1, TH and DAT mRNA expression.The results might suggest a new strategy to provide enough dopaminergic cells for the therapy of Parkinson's disease (PD), and Nurr1 and ERK signaling pathway might participate in the AA-induced DAergic differentiation.     

酿酒酵母蛋白酶A外泌与酒类酿造

蛋白酶A(EC 3.4.23.6)是酿酒酵母中重要的蛋白酶,与酶原激活、生孢等多种生理功能密切相关.在酒类酿造过程中往往会发生蛋白酶A外泌进而影响发酵产品质量的现象.研究胁迫条件下蛋白酶A的外泌及其调控机制,对于酿酒酵母菌种选育和酒类产品质量控制具有重要的理论指导意义.本文主要对蛋白酶A外泌机制和蛋白酶A外泌对酒类酿造影响的相关研究进行综述.     

基于非负矩阵分解技术探寻早期阿尔茨海默症基因表达调控网络

本文利用非负矩阵分解(NMF)技术,依据加强算法的稀疏性对患早期阿尔茨海默 症(Alzheimer’s Disease,AD)样本的基因表达数据进行了分析,提取了对疾病早期诊断具有重 要意义的显著基因,样本分类实验结果证明了算法的有效性。在此基础上,结合与炎症反应 有重要关系的 NF-κB 等基因初步建立了与早期 AD 密切相关的基因表达调控网络结构图, 为 AD 致病机理的探询、早期诊断与治疗等提供了有益的途径和方法。     

用AFM观察小白鼠心肌核DNA片段的基因体外转录和垃圾DNA的相互作用

用AFM直接观察、体外转录等实验技术组合,发现小白鼠(Balb/C)心肌体外转录状态的核DNA片段上的各种基因,处于垃圾DNA的特定的“转录平台”上。“转录平台”上的各种核活性基因的两端的调控序列,分别与特定开关蛋白质复合体结合(即可解离的开关蛋白质),中间的编码序列分别以非共价键特异结合可完全解离的转录活性因子等多种蛋白质;这些与核基因转录相关的蛋白质均由垃圾DNA的专一性蛋白质通路分别进行特异性正负反馈调控。     

Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites

Aldose reductase and aldehyde reductase belong to the aldo-keto reductase superfamily of enzymes whose members are responsible for a wide variety of biological functions. Aldose reductase has been identified as the first enzyme involved in the polyol pathway of glucose metabolism which converts glucose into sorbitol. Glucose over-utilization through the polyol pathway has been linked to tissue-based pathologies associated with diabetes complications, which make the development of a potent aldose reductase inhibitor an obvious and attractive strategy to prevent or delay the onset and progression of the complications. Structural studies of aldose reductase and the homologous aldehyde reductase in complex with inhibitor were carried out to explain the difference in the potency of enzyme inhibition. The aim of this review is to provide a comprehensive summary of previous studies to aid the development of aldose reductase inhibitors that may have less toxicity problems than the currently available ones. Received 4 December 2006; received after revision 12 February 2007; accepted 20 April 2007